Assigning new function to a known drug: Metformin, the widely used drug in the treatment of NIDDM, functions as a “radiosensitizer” in lung cancer via up regulation of its target gene Sestrin1, 19/August/2014, 08.16 am

MiRNA-based therapy for cancer: MiRNA-1287 decreases the expression of immortality gene telomerase via down regulation of its target gene, 19/August/2014, 08.09 am
August 19, 2014
AntagomiR-based therapy for Myocardial infarction: MiRNA Let-7g decreases myocardial survival post myocardial infarction via down regulation of aldehyde dehydrogenase 2, 19/August/2014, 08.27 am
August 19, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Assigning new function to a known drug: Metformin, the widely used drug in the treatment of NIDDM, functions as a “radiosensitizer” in lung cancer via up regulation of its target gene Sestrin1, 19/August/2014, 08.16 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Pharmacological relevance: This study suggests the mechanism by which Metformin functions as a radiosensitizer. Furthermore, this study suggests that Metformin can be used to radiosensitize lung cancer cells.
 * Research cooperation

Comments are closed.